# Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests

> **NCT01989897** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Bryan Martin, DO**

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** saline with 1mg/ml Histamine base
- **DRUG:** diluent, saline with HSA--phenol

## Key facts

- **NCT ID:** NCT01989897
- **Lead sponsor:** Bryan Martin, DO
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding for the trial was lost so study was ended. No participants were enrolled.
- **Last updated:** 2021-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01989897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01989897, "Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01989897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*